AlShareef Saad Mohammed
Department of Medicine, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 13317-4233, Saudi Arabia.
J Asthma Allergy. 2023 Jul 20;16:735-742. doi: 10.2147/JAA.S421175. eCollection 2023.
The European Community Respiratory Health Survey (ECRHS) questionnaire has been widely used in epidemiological studies to quantify respiratory symptoms and screen for asthma, but there is no formally validated Arabic version. This study developed an Arabic ECRHS screening questionnaire, comprehensively evaluated its reliability and validity, and used it to estimate the population prevalence of respiratory symptoms and asthma in Saudi Arabia.
The ECRHS screening questionnaire was adapted to Arabic through translation and back-translation by bilinguals with consultation to a professional committee and lay panel. Reliability and validity were evaluated in a prospective, cross-sectional convenience sample of adults (>18 years) between January and July 2022 in Riyadh, Saudi Arabia. A subgroup completed the questionnaire again three weeks later to assess test-retest reliability. All respiratory symptom-positive participants were invited for spirometry to diagnose asthma according to GINA criteria. Internal consistency was assessed using Cronbach's α coefficient, test-retest reliability with Cohen κ coefficients, and reliability by calculating the sensitivity and specificity for diagnosing asthma.
Of 2500 invited individuals, 1881 participated (75.2%). A total of 668 (35.5%) participants reported respiratory symptoms according to the ECRHS questionnaire, and 157/1881 (8.3%) had a current diagnosis of asthma on ECRHS questions. Cronbach's α coefficient for internal consistency was 0.831, "good" internal consistency. The test-retest reliability (n = 303) was "excellent" for all questions (Cohen's κ≥0.75). A total of 543 (81.3%) screening-positive participants underwent spirometry, of whom 278 (52%) were diagnosed with asthma according to GINA guidelines, an overall estimated prevalence of 14.8%. Most questions showed good-to-fair specificity and variable sensitivity for physician-diagnosed asthma.
This Arabic version of the ECRHS screening questionnaire is conceptually similar to the English version, comprehensible, and reliable. Many asthma cases remain hidden and undiagnosed. In addition to utility in epidemiological studies, the ECRHS screening questionnaire might be a simple, quick, and useful tool for asthma case finding.
欧洲共同体呼吸健康调查(ECRHS)问卷已广泛用于流行病学研究,以量化呼吸道症状并筛查哮喘,但尚无经过正式验证的阿拉伯语版本。本研究开发了一份阿拉伯语ECRHS筛查问卷,全面评估其信度和效度,并用于估计沙特阿拉伯呼吸道症状和哮喘的人群患病率。
通过双语人员进行翻译和回译,并咨询专业委员会和普通小组,将ECRHS筛查问卷改编为阿拉伯语。于2022年1月至7月在沙特阿拉伯利雅得对年龄大于18岁的成年人进行前瞻性横断面便利抽样,评估其信度和效度。一个亚组在三周后再次填写问卷,以评估重测信度。邀请所有呼吸道症状呈阳性的参与者进行肺功能测定,以根据全球哮喘防治创议(GINA)标准诊断哮喘。使用Cronbach's α系数评估内部一致性,使用Cohen κ系数评估重测信度,并通过计算诊断哮喘的敏感性和特异性评估信度。
在2500名受邀者中,1881人参与(75.2%)。根据ECRHS问卷,共有668名(35.5%)参与者报告有呼吸道症状,157/1881(8.3%)在ECRHS问题上目前被诊断为哮喘。内部一致性的Cronbach's α系数为0.831,内部一致性“良好”。所有问题的重测信度(n = 303)“优秀”(Cohen's κ≥0.75)。共有543名(81.3%)筛查呈阳性的参与者进行了肺功能测定,其中278名(52%)根据GINA指南被诊断为哮喘,总体估计患病率为14.8%。大多数问题对医生诊断的哮喘显示出良好至中等的特异性和可变的敏感性。
这份阿拉伯语版的ECRHS筛查问卷在概念上与英语版相似,易于理解且可靠。许多哮喘病例仍未被发现和诊断。除了在流行病学研究中的效用外,ECRHS筛查问卷可能是一种简单、快速且有用的哮喘病例发现工具。